$1.80
In chiusura: Oct 3, 3:50 PM EDT
Finch Therapeutics Gr segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Finch Therapeutics Gr utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
FNCH | Finch Therapeutics Gr | -$3.01 | — | — | — | $0.00 | — | — | — | 10/17/2025 | |
FNCH | Finch Therapeutics Gr | -$4.33 | — | -$3.01 | — | $0.00 | — | $0.00 | — | 08/13/2024 | |
FNCH | Finch Therapeutics Gr | -$9.30 | — | -$2.41 | — | $107.00K | — | $0.00 | — | 05/10/2024 | |
FNCH | Finch Therapeutics Gr | -$16.80 | — | -$1.89 | — | $8.00K | — | $0.00 | — | 03/25/2024 | |
FNCH | Finch Therapeutics Gr | -$25.38 | — | -$1.51 | — | $138.00K | — | $0.00 | — | 11/08/2023 | |
FNCH | Finch Therapeutics Gr | -$14.40 | — | -$4.33 | — | $361.00K | — | $0.00 | — | 08/10/2023 | |
FNCH | Finch Therapeutics Gr | -$15.60 | — | -$9.30 | — | $354.00K | — | $107.00K | — | 05/10/2023 | |
FNCH | Finch Therapeutics Gr | -$12.00 | -$10.20 | -$16.80 | -64.71% | $806.00K | $400.00K | $8.00K | -98.00% | 03/23/2023 | |
FNCH | Finch Therapeutics Gr | -$6.30 | -$12.00 | -$13.50 | -12.50% | $11.34M | $750.00K | $138.00K | -81.60% | 11/10/2022 | |
FNCH | Finch Therapeutics Gr | -$9.60 | — | -$14.40 | — | $2.83M | — | $361.00K | — | 08/11/2022 | |
FNCH | Finch Therapeutics Gr | -$30.00 | — | -$15.60 | — | $3.55M | — | $354.00K | — | 05/16/2022 | |
FNCH | Finch Therapeutics Gr | -$46.80 | -$9.60 | -$12.00 | -25.00% | $1.81M | — | $806.00K | — | 03/31/2022 | |
FNCH | Finch Therapeutics Gr | -$36.60 | -$12.60 | -$6.30 | 50.00% | $1.77M | — | $11.34M | — | 11/10/2021 | |
FNCH | Finch Therapeutics Gr | -$30.60 | -$8.40 | -$9.60 | -14.29% | $2.35M | — | $2.83M | — | 08/10/2021 | |
FNCH | Finch Therapeutics Gr | -$30.00 | -$7.20 | -$30.00 | -316.67% | $1.79M | — | $3.55M | — | 05/13/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q4 | 2023-03-23 | $-16.80 | $-10.20 | -64.7 % |
Q3 | 2022-11-10 | $-13.50 | $-12.00 | -12.5 % |
Q4 | 2022-03-31 | $-12.00 | $-9.60 | -25.0 % |
Q3 | 2021-11-10 | $-6.30 | $-12.60 | 50.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q4 | 2023-03-23 | $8.00K | $400.00K | -98.0 % |
Q3 | 2022-11-10 | $138.00K | $750.00K | -81.6 % |
Si prevede che Finch Therapeutics Gr (FNCH) fornisca risultati il ottobre 17, 2025. Gli ultimi risultati sono stati pubblicati il agosto 13, 2024 per il Q2.
L'EPS effettivo era $-3.01, che mancato la stima di $0.00.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.